Also known as: Rasmussen syndrome
Rasmussen encephalitis (RE) or Rasmussen syndrome is a rare progressive inflammatory condition of one hemisphere (side) of the brain. The disease stays on one hemisphere of the brain; only rarely has it been reported to spread to the other hemisphere. The inflammation leads to loss of brain tissue (atrophy) and scarring. Although RE is most often diagnosed in children under the age of ten years, it can also start in adolescence and adulthood; in this population, the course of the disease is usually milder.
Last updated November 2013 by Dr Sophia Varadkar, Consultant Paediatric Neurologist, Great Ormond Street Hospital, London.
Most children present with seizures (see entry Epilepsy) involving one side of the body (focal epilepsy). The epilepsy is usually difficult to control. As time goes on, children also become weak on the same side of the body as the seizures. This weakness usually becomes permanent (hemiplegia) and they lose some of their visual fields (they can still see, just not in every direction). Children also begin to have problems with their learning (cognitive decline). Eventually they are likely to have learning disability. They may have particular problems with speech if the side of the brain controlling language is involved (language dominant hemisphere). For some children these symptoms and their severity progress very quickly over months, for others the disease goes slowly over years.
Whilst we do not know what triggers RE, we do know that RE is an autoimmune disorder. This means that T lymphocytes, a type of white blood cell, are involved in the inflammation and damage of the brain tissue.
Diagnosis is based on the clinical picture of epilepsy, emerging weakness, MRI brain scans showing the loss and damage to brain tissue, and electroencephalographs (EEG) showing abnormal electrical activity in the brain. There is no specific blood test, and brain biopsies are not needed to make the diagnosis.
Anti-epileptic drugs can help to control seizures (see entry Epilepsy), but they do not stop the condition. There are also treatments targeting the autoimmune basis of RE. These include oral steroids, azathioprine, tacrolimus and intravenous immunoglobulins, although new medical treatments are being considered, so this list is not complete. However, it is important to remember that, whilst these treatments may slow down RE, they do not cure it.
Surgery is the only treatment known to stop RE. The affected side of the brain is disconnected from the healthy brain (the operation is usually called a functional hemispherectomy). Unfortunately, while surgery is very good at stopping seizures, it does result in a permanent weakness on one side of the body (hemiplegia) and visual field loss (if the child doesn’t already have these as a result of RE). Deciding on surgery should be done by the family, young person, doctors and a specialist epilepsy surgery service.
Information and support in the UK for Rasmussen’s encephalitis is provided by the Encephalitis Society (see entry Encephalitis).